We are live on
!
Find out more
PCM
Poehling Capital Management Portfolio holdings
AUM
$466M
1-Year Est. Return
24.17%
This Fund
S&P 500
This Quarter
Est. Return
-2.54%
1 Year Est. Return
+24.17%
3 Year Est. Return
+70.93%
5 Year Est. Return
+69.6%
10 Year Est. Return
–
AUM
$296M
AUM Growth
-$17.8M
(-5.7%)
Cap. Flow
+$34.6M
Cap. Flow
% of AUM
11.7%
Top 10 Holdings %
Top 10 Hldgs %
30.56%
Holding
155
New
7
Increased
44
Reduced
57
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sonoco
SON
|
+$41.7M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$4.97M |
| 3 |
Organon & Co
OGN
|
+$3.36M |
| 4 |
iShares Silver Trust
SLV
|
+$2.48M |
| 5 |
Viatris
VTRS
|
+$2.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
|
+$5.82M |
| 2 |
RBAC
RedBall Acquisition Corp.
RBAC
|
+$2.79M |
| 3 |
WPF.U
Foley Trasimene Acquisition Corp.
WPF.U
|
+$2.59M |
| 4 |
Philip Morris
PM
|
+$2.13M |
| 5 |
WPF.WS
Foley Trasimene Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
WPF.WS
|
+$1.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.46% |
| 2 | Healthcare | 16.23% |
| 3 | Communication Services | 9.08% |
| 4 | Technology | 9.05% |
| 5 | Consumer Discretionary | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class B
BRK.B
$1.12T
| $17.6M | 5.94% |
64,465
-164
| -0.3% | -$46.1K |
|
2
Apple
AAPL
$4.52T
| $10.8M | 3.66% |
76,581
-237
| -0.3% | -$34.9K |
|
3
Alphabet (Google) Class C
GOOG
$4.59T
| $8.81M | 2.98% |
66,140
-100
| -0.2% | -$13.8K |
|
4
Cannae Holdings
CNNE
$660M
| $8.65M | 2.92% |
277,901
+38,298
| +16% | +$1.23M |
|
5
Markel Group
MKL
$23.4B
| $8.34M | 2.82% |
6,982
-6
| -0.1% | -$7.4K |
|
|
6
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$154M
| $7.55M | 2.55% |
16,955
+11,095
| +189% | +$4.97M |
|
|
7
Organon & Co
OGN
$3.56B
| $7.43M | 2.51% |
226,513
+105,043
| +86% | +$3.36M |
|
8
Microsoft
MSFT
$3.66T
| $7.31M | 2.47% |
25,932
-1,028
| -4% | -$299K |
|
9
Wells Fargo
WFC
$267B
| $7.08M | 2.39% |
152,534
-8,644
| -5% | -$400K |
|
10
Marathon Petroleum
MPC
$91.3B
| $6.9M | 2.33% |
111,687
-2,929
| -3% | -$168K |
|
11
CVS Health
CVS
$133B
| $6.81M | 2.3% |
80,230
+9
| +0% | +$754 |
|
|
12
Viatris
VTRS
$20.6B
| $6.52M | 2.2% |
481,464
+158,045
| +49% | +$2.24M |
|
13
KKR & Co
KKR
$97.2B
| $5.66M | 1.91% |
92,903
-1,663
| -2% | -$104K |
|
14
Mastercard
MA
$500B
| $5.53M | 1.87% |
15,918
-175
| -1% | -$63.6K |
|
15
Invesco
IVZ
$14.1B
| $5.22M | 1.76% |
216,529
-6,547
| -3% | -$164K |
|
16
Visa
V
$690B
| $5.15M | 1.74% |
23,136
-706
| -3% | -$166K |
|
17
Jefferies Financial Group
JEF
$12.8B
| $4.72M | 1.59% |
133,057
-34
| -0% | -$1.14K |
|
18
AbbVie
ABBV
$431B
| $4.65M | 1.57% |
43,070
+3,641
| +9% | +$416K |
|
|
WBA
19
DELISTED
Walgreens Boots Alliance
WBA
| $4.38M | 1.48% |
93,016
+9,511
| +11% | +$459K |
|
20
Apollo Global Management
APO
$76.8B
| $4.24M | 1.43% |
68,908
-2,553
| -4% | -$153K |
|
21
Citigroup
C
$230B
| $3.92M | 1.32% |
55,821
+733
| +1% | +$51.2K |
|
22
Warner Bros
WBD
$64.7B
| $3.9M | 1.32% |
153,659
+20,794
| +16% | +$585K |
|
23
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
| $3.72M | 1.26% |
142,760
-7,062
| -5% | -$175K |
|
|
PARA
24
DELISTED
Paramount Global Class B
PARA
| $3.68M | 1.24% |
93,056
+8,442
| +10% | +$344K |
|
25
GraniteShares Gold Shares
BAR
$1.37B
| $3.67M | 1.24% |
210,428
+26,813
| +15% | +$477K |
|
Similar funds
UC
JHC
HP
ACGA
PC
VCM
SP
KWS
Poehling Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Poehling Capital Management held 155 positions worth $296M, down 5.7% from $314M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Poehling Capital Management deployed $34.6M of net new capital in Q3 2021, opening 7 new positions and adding to 44 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 11,062 shares worth $1.44M.
By sector, the portfolio is most concentrated in Financials at 34% of assets, down from 35% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Philip Morris, an estimated $2.13M trimmed.
- Poehling Capital Management's largest Q3 2021 buy was Jazz Pharmaceuticals: 11,062 shares worth $1.44M.
- Poehling Capital Management added most to Sonoco in Q3 2021, an estimated $41.7M increase.
- Poehling Capital Management's biggest Q3 2021 reduction was Philip Morris, cutting an estimated $2.13M.
- Poehling Capital Management fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2021, selling an estimated $5.82M.
- Poehling Capital Management's ten largest holdings make up 31% of its $296M portfolio in Q3 2021.
- Poehling Capital Management opened 7 new positions and closed 20 in Q3 2021.
- Poehling Capital Management's portfolio value fell 5.7% quarter-over-quarter to $296M.
Based on Poehling Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.